Vaccination Response Modulation With a Targeted Rapamycin Protocol Study

NCT07587801 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Vaccine Immune Response
Haemodialysis Patients
Older Adults

Interventions

DRUG: Sirolimus (RAPAMUNE)
BIOLOGICAL: Influenza vaccine (Sequiris Fluad Quad)
BIOLOGICAL: RSV vaccine (Pfizer Abrysvo)

Sponsor

Central Adelaide Local Health Network Incorporated